I don’t think it will be a wash either way. Mainly because of the DSMC recommendation to look at mortality at 42 day as well as other studies I have seen an additional 10-20% mortality after day 28 in severe critical. If we assume we hit 89 deaths and than take off 10% of them that may happen outside of 28 day period than overall mortality will have dropped to 80/390 20.5%

30 % morality Placebo 39/130 30%
15.7% mortality Leronlimab 41/260 15.7%

This would be remarkable numbers if we’re anywhere close to this.